Results 21 to 30 of about 101,164 (260)

High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients Treated with Adjuvant Chemotherapy [PDF]

Journal of Pathology and Translational Medicine, 2018
Background Chemokine receptor CXC chemokine receptor type 4 (CXCR4) and its ligand CXC motif chemokine 12 (CXCL12; stromal cell-derived factor-1) are implicated in tumor growth, metastasis, and tumor cell-microenvironment interaction. A number of studies
Bobae Shim, Min-Sun Jin, Ji Hye Moon, In Ae Park, Han Suk Ryu   +4 more
doaj   +1 more source

Modern View on the Problem of Triple Negative Breast Cancer

, 2023
Environmental pollution, repeated artificial termination of pregnancy, and improper use of medications create conditions for the development of breast cancer (BC). According to the World Health Organization, “... throughout the world, breast cancer ranks
Atakhanova N. E, Almuradova D. M, Ziyaev Sh. V   +2 more
core   +1 more source

Immunotherapy in triple-negative breast cancer: mechanisms of resistance and emerging approaches: a narrative review [PDF]

Journal of Yeungnam Medical Science
Triple-negative breast cancer (TNBC) is characterized by less treatment responsiveness and poorer prognosis than other breast cancer subtypes. The introduction of anti-programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) immunotherapy ...
Sung Ae Koh
doaj   +1 more source

Chitosan nanoparticles containing limonene and limonene-rich essential oils: potential phytotherapy agents for the treatment of melanoma and breast cancers

BMC Complementary Medicine and Therapies, 2021
Background Melanoma and breast cancers are two common cancers worldwide. Due to the side effects of chemotherapy drugs and the occurring resistance against them, the development of green drugs has been received more attention.
Hiva Alipanah, Mojtaba Farjam, Elham Zarenezhad, Ghazaal Roozitalab, Mahmoud Osanloo   +4 more
doaj   +1 more source

Impressive effect of cisplatin monotherapy on a patient with heavily pretreated triple-negative breast cancer with poor performance [PDF]

Yeungnam University Journal of Medicine, 2020
Systemic therapy for metastatic triple-negative breast cancer (TNBC) still remains challenging because there are no targeted agents or endocrine therapies currently available.
Dong Won Baek, Ji-Young Park, Soo Jung Lee, Yee Soo Chae   +3 more
doaj   +1 more source

Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem [PDF]

, 2023
Based on compelling preclinical evidence concerning the progress of our novel ruthenium-based metallotherapeutics, we are focusing research efforts on challenging indications for the treatment of invasive neoplasms such as the triple-negative breast ...
Irace C., Paduano L., Montesarchio D., Piccolo M., Misso G., Bocchetti M., Riccardi C., Trifuoggi M., Santamaria R., Ferraro M. G.   +9 more
core   +2 more sources

Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer [PDF]

Revista Brasileira de Ginecologia e Obstetrícia
Objective Neoadjuvant chemotherapy (NACT) has become the standard of care for patients with triple-negative breast cancer (TNBC) with tumors > 1 cm or positive axillary nodes.
Maria Fernanda Imperio Pereira, Isabela Panzeri Carlotti Buzatto, Hélio Humberto Angotti Carrara, Fabiana de Oliveira Buono, Jurandyr Moreira de Andrade, Leonardo Fleury Orlandini, Daniel Guimarães Tiezzi   +6 more
doaj   +1 more source

Table_1_Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer.XLSX

, 2022
BackgroundAdenoid cystic carcinoma (ACC) is a rare type of triple-negative breast cancer that has an indolent clinical behavior. Given the substantial overlapping morphological, immunohistochemical, and molecular features with other basal-like triple ...
Qian Yao (1451017), Junbing Chen (13165587), Xiaozheng Huang (13165593), Yanhua Bai (13165590), Dongfeng Niu (316658), Wei Hou (48073), Mengping Long (8407833), Lixin Zhou (80162), Chen Zhao (225070)   +8 more
core   +1 more source

Urinary cholesterol excretion in men with benign prostatic hyperplasia and carcinoma of the prostate [PDF]

, 1977
Urinary excretion of nonesterified (NEC) and total cholesterol (TC) has been investigated in 79 patients with prostatic adenoma (BPH) and 48 patients with carcinoma of the prostate.
P. GIORDANO, Odom, Lorrie F., Ruiz Jorge, Lissette, Williams, Fiona L. R., Llombart-Bosh, Antonio, Angelika, Pickel, McNeely, Lee K., McCarthy, Donna O., Roy, S., Meagher, David P., Jr., G. MAZZINI, Kumar, Lalit, Bhangui, G. R., Daniel, William E., Lloyd, Owen L., Tandon, P. N., Alegret Rodríguez, Milagros, Pickel, A., Kochupillai, V., Elsässer, Erich, Machado Puerto, Isidro, Karl, Hans Josef, E. TRAVERSI, Dua, Harsch, Stadler, Alexander, Cowpe, Jonathan G., Green, Michael, Jüngst, Dieter, Blake, Marilyn, Marx, Franz J., Poole, Marten A., Haase, Gerald M., Ogden, Graham R.; id_orcid, E. ASCARI, MONTECUCCO, CARLOMAURIZIO, A. RICCARDI   +35 more
core   +1 more source

Image_1_Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer.TIF

, 2022
BackgroundAdenoid cystic carcinoma (ACC) is a rare type of triple-negative breast cancer that has an indolent clinical behavior. Given the substantial overlapping morphological, immunohistochemical, and molecular features with other basal-like triple ...
Qian Yao (1451017), Junbing Chen (13165587), Xiaozheng Huang (13165593), Yanhua Bai (13165590), Dongfeng Niu (316658), Wei Hou (48073), Mengping Long (8407833), Lixin Zhou (80162), Chen Zhao (225070)   +8 more
core   +1 more source